Rising Threat of Head and Neck Cancers
Head and neck cancers are increasing, affecting survival and prevalence rates.
Andrea Miquel Dominguez, Eng Hooi Tan, Edward Burn, Antonella Delmestri, Talita Duarte-Salles, Asieh Golozar, Wai Yi Man, Daniel Prieto-Alhambra, Francesc Xavier Avilés-Jurado, Danielle Newby
― 7 min read
Table of Contents
- Why Do We Need to Know About Different Types?
- What's Happening with Head and Neck Cancers?
- How Was the Study Done?
- What Did the Researchers Look For?
- Who Were the Patients?
- How Do Incidence Rates Look?
- What About the Prevalence of HNC?
- Survival Rates: How Are They Looking?
- Why Are These Trends Happening?
- What Are the Limitations of This Study?
- Conclusion: What Can We Take Away?
- Original Source
Head and neck cancers (HNC) are a group of cancers that affect various parts of the upper aerodigestive tract. This includes the mouth, throat, voice box, sinuses, and salivary glands. Together, these cancers are quite common, with over 660,000 new cases and about 325,000 deaths globally each year. That's like an entire small town disappearing every year!
Why Do We Need to Know About Different Types?
Each type of head and neck cancer has its own unique traits. They can vary in how they look under a microscope, the symptoms they cause, the treatments they require, and the chances of recovery. Because of these differences, it's important to treat each type as a separate case rather than lumping them all together. Think of it like a box of chocolates: not every piece is going to taste the same!
What's Happening with Head and Neck Cancers?
In recent years, the number of people diagnosed with HNC has been on the rise, especially in the UK and other countries. While there have been some improvements in Survival Rates, the overall trend shows that more people are facing these cancers. Certain lifestyle choices, like smoking and drinking alcohol, as well as infections like the human papillomavirus (HPV), can up the risk for these cancers.
As we see changes in HPV infections and vaccinations, and as fewer people smoke and drink heavily, it's vital to stay up to date with the data on HNC. This study aims to look at trends in incidence, prevalence, and survival rates for HNC from 2000 to 2021 using health data from the UK.
How Was the Study Done?
The researchers used data collected from general practitioners across the UK. They identified patients diagnosed with head and neck cancers and compared those with a general population group from two databases: CPRD GOLD and CPRD Aurum. These databases contain a lot of information about patients, including their lifestyles, medical history, and what treatments they received. It’s like having a super detailed diary for each person.
For this study, they looked at all patients who were at least 18 years old and had been in the database for at least a year, starting from January 1, 2000. The patients were followed until they either received a diagnosis of HNC, left the database, died, or until the study ended on December 31, 2021.
What Did the Researchers Look For?
To track the trends in head and neck cancers, the researchers defined what they were measuring. They focused on:
- Incidence Rates: How many new cases are being diagnosed?
- Prevalence Rates: How many people are currently living with HNC?
- Survival Rates: How long do patients live after being diagnosed?
Using this information allows healthcare professionals to make better decisions about screening, prevention, and treatment for HNC patients.
Who Were the Patients?
More than 11 million patients were eligible for the study. In this population, they found 12,455 patients diagnosed with head and neck cancers. Most of these patients were male (about 69%) with a median age of 64. The largest group of diagnosed patients was aged 60 to 69 years. It looks like the older you get, the more your chances increase—no one particularly likes that statistic!
Among the different types of HNC, cancers of the larynx (voice box), tongue, and oropharynx (part of the throat) were the most common. On the flip side, cancers of the nasal cavity and sinuses were the least common. It seems like your voice box and tongue get more attention than your nose!
How Do Incidence Rates Look?
From 2000 to 2021, the overall incidence rate of HNC was about 14.2 cases per 100,000 people. Males had a higher incidence rate than females—20.0 for men compared to 8.6 for women. The most common type of HNC was Laryngeal Cancer (3.2 cases per 100,000), while nasal cavity cancers were rare (0.3 cases per 100,000).
Interestingly, rates for some types of HNC have been increasing over the years, especially for cancers like those of the oropharynx, tongue, and salivary glands. Meanwhile, laryngeal cancer seems to be leveling off or even decreasing in some cases. It’s like a rollercoaster ride where some cars are still climbing while others are on their way down.
What About the Prevalence of HNC?
The annual prevalence of HNC has increased significantly over time, with the most recent figures showing a prevalence of 0.13% in 2021. Men had a higher prevalence than women. This increase is thought to be due to the aging population, as older age groups are more prone to developing these cancers.
Different subsites of HNC had varying prevalence rates, with tongue, larynx, and oropharynx cancers being the most common. On the other hand, nasal cavity and sinus cancers lagged behind in terms of prevalence—not a great spotlight moment for them!
Survival Rates: How Are They Looking?
The study showed that the median survival rate for HNC patients was about 7 years. For those diagnosed, the chances of surviving one, five, and ten years after diagnosis were 81%, 56%, and 41%, respectively. Females generally had a better chance of survival than males, with a median survival of around 8.2 years compared to 6.5 years for males.
Certain types of cancers had poorer survival rates. For instance, patients with hypopharyngeal cancer tended to have a median survival rate of around 3.4 years. On the contrary, those with oral cavity cancers fared better, living an average of 8.7 years.
High fives were given to the researchers because they found that overall survival rates have seen a slight upward trend in the long term, yet the short-term outcomes haven't improved significantly. It’s as if we’re inching forward, but not racing ahead.
Why Are These Trends Happening?
The increase in head and neck cancers can be attributed to several factors. On one side, we have lifestyle choices like smoking and drinking, which are known to increase risks for these cancers. Despite a decline in smoking rates—thanks, anti-tobacco campaigns!—the overall numbers still seem to go up.
Another factor contributing to the rise may be linked to HPV infections, especially in cancers like oropharyngeal cancer. There’s a growing awareness of HPV’s role in these cancers, yet the data suggests a complicated picture.
For head and neck cancers, it’s clear that many things can influence the statistics, from lifestyle to infections, all blended together in a complex mix.
What Are the Limitations of This Study?
Although the study used data from two big databases covering more than 20 years, it had its limitations. One key issue is that the researchers used primary care data without linking it to cancer registers. This might lead to missed cases or misclassifications.
Also, because they didn't have information on tumor genetics or treatments, this study couldn't dive deeply into how these factors might affect survival. There’s also the risk of incorrectly categorizing cancers since different areas of the head and neck are often closely related anatomically.
Conclusion: What Can We Take Away?
The increasing incidence and prevalence of head and neck cancers on the rise might be a cause for concern, especially among older adults. It seems that while we’re seeing some progress in long-term survival, the short-term outcomes are lagging behind.
Whether it's through better prevention strategies, earlier diagnosis, or improved treatment plans, there's still much work to do! As we continue to dig deeper into the trends and patterns of HNC, we aim for a future where fewer people have to face these challenges and more can celebrate their victories over cancer.
In a world of uncertainty, knowledge is key. And maybe, just maybe, we can all play a part in reducing these statistics in the years to come.
Original Source
Title: Incidence, prevalence, and survival of head and neck cancers in the United Kingdom from 2000-2021
Abstract: ImportanceIncidence, prevalence, and survival are important measures to inform the management and provision of head and neck cancer care. ObjectiveTo calculate the incidence, prevalence, and survival rates for head and neck cancers and subsites in the UK from 2000 to 2021. Design, Setting, and ParticipantsThis population-based cohort study uses routinely collected primary care data from the UK. Patients aged 18 years or older with at least 1 year of history registered in Clinical Practice Research Datalink (CPRD) GOLD or Aurum were included. Data were analyzed from January 2023 to March 2024. Main Outcomes and MeasuresHead and neck cancer incidence rates (IR), period prevalence (PP), and one-, five-, and ten-year survival after diagnosis between 2000 and 2021, stratified by age and calendar years. ResultsThere were 12,455 HNC patients (male 69.2%) with a median age of 64 years. Crude incidence increased from 9.08 (7.88 to 10.42) per 100 000 person-years in 2000 to 15.59 (14.07 to 17.23) in 2021 in CPRD GOLD with similar rates in Aurum. Age standardization attenuated incidence rises for HNC subsites apart from oropharynx and tongue. Prevalence increased for both databases, from 0.04% in 2000 to 0.12% in 2019. HNC five-year survival increased from 53.8% (95% CI, 51.4% - 56.3%) in 2000-2004 to 58.7% (56.5 - 60.9%) in 2015 to 2019. Conclusions and RelevanceHNC increases over recent decades are likely due to ageing with increases in specific subsites such as oropharyngeal cancers are due to other behavioural risk factors. Small improvements in survival highlights more research is needed to improve earlier diagnosis which will lead to better patient outcomes. KEY POINTSO_ST_ABSQuestionC_ST_ABSWhat is the disease burden of the head and neck cancers (HNC) in UK from 2000-2021? FindingsFor all HNC combined, incidence and prevalence have increased with five-year survival slightly improving over time. Variation in results were observed for different subsites. MeaningOur findings show increases in HNC are likely due to ageing with increases in certain subsites due to other behavioural risk factors. The small increase in survival highlights more research is needed to improve earlier diagnosis leading to better patient outcomes.
Authors: Andrea Miquel Dominguez, Eng Hooi Tan, Edward Burn, Antonella Delmestri, Talita Duarte-Salles, Asieh Golozar, Wai Yi Man, Daniel Prieto-Alhambra, Francesc Xavier Avilés-Jurado, Danielle Newby
Last Update: 2024-12-06 00:00:00
Language: English
Source URL: https://www.medrxiv.org/content/10.1101/2024.12.05.24318538
Source PDF: https://www.medrxiv.org/content/10.1101/2024.12.05.24318538.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to medrxiv for use of its open access interoperability.